Japan proposes "unacceptable" requirements for biomaterials
This article was originally published in Clinica
Executive Summary
The Japanese Ministry of Health and Welfare (MHW) is proposing to expand the information it requires for the premarket approval (PMA) of devices containing biomaterials.